Medical Imaging Techniques
Radiopharmaceuticals in Medical Imaging
Radiopharmaceuticals are radioactive substances given to patients that target specific organs, tissues, or physiological processes. Once inside the body, they emit gamma radiation that's detected externally by a gamma camera or scanner. The resulting images show how the radiopharmaceutical is distributed and concentrated throughout the body.
Different radiopharmaceuticals serve different diagnostic purposes:
- Technetium-99m () is the most commonly used radiopharmaceutical, applied in bone scans, cardiac imaging, and brain imaging
- Iodine-131 () is used for thyroid imaging and thyroid disease treatment
- Fluorine-18 () is used in positron emission tomography (PET) scans
What makes radiopharmaceuticals powerful is that they provide functional and molecular imaging. Rather than just showing anatomy (like an X-ray does), they reveal physiological processes and biochemical pathways. This helps doctors diagnose and monitor diseases such as cancer, heart disease, and neurological disorders.
Contrast agents may also be used alongside these techniques to enhance visibility of specific structures or tissues.
SPECT vs. PET Imaging Techniques
Both SPECT and PET are nuclear medicine imaging techniques that use radiopharmaceuticals, but they work differently and have distinct strengths.
SPECT (Single Photon Emission Computed Tomography)
- Uses radiopharmaceuticals that emit single gamma photons
- A gamma camera rotates around the patient, acquiring multiple 2D images from different angles. These are then reconstructed into a 3D representation of radiopharmaceutical distribution.
- Provides functional information about organs and tissues
- Has lower spatial resolution compared to PET
PET (Positron Emission Tomography)
- Uses radiopharmaceuticals that emit positrons (the antimatter counterpart of electrons). When a positron meets an electron, they annihilate each other and produce two gamma photons that travel in exactly opposite directions (180° apart).
- A ring of detectors surrounding the patient picks up both photons nearly simultaneously. This coincidence detection allows precise localization of where the annihilation occurred.
- Provides functional and molecular information with higher spatial resolution than SPECT
- Most commonly uses fluorine-18 fluorodeoxyglucose (), which measures glucose metabolism in tissues. Since cancer cells tend to consume more glucose, PET is especially useful for detecting tumors.
Comparing the two: SPECT is more widely available and less expensive, making it the workhorse of many hospitals. PET offers higher sensitivity and spatial resolution, which is particularly useful for early disease detection and monitoring treatment response.
Additional Imaging Techniques
These non-nuclear techniques round out the medical imaging toolkit:
- Computed Tomography (CT): Uses X-rays taken from many angles to create detailed cross-sectional images of the body. Great for visualizing bone injuries, internal bleeding, and tumors.
- Magnetic Resonance Imaging (MRI): Uses strong magnetic fields and radio waves to produce high-resolution images of soft tissues. No ionizing radiation is involved, making it preferable for brain, spinal cord, and joint imaging.
- Ultrasound: Uses high-frequency sound waves to create real-time images of internal organs and structures. Commonly used in prenatal imaging and for examining the heart and abdomen.
- X-ray: Produces 2D images best suited for dense structures like bones. Also useful for detecting certain lung conditions such as pneumonia.
Each technique has trade-offs in terms of resolution, cost, radiation exposure, and what types of tissue it images best. Doctors choose the method based on what they need to see.
Medical Testing Techniques
Radioimmunoassay (RIA) for Medical Testing
Radioimmunoassay (RIA) is a highly sensitive lab technique for measuring tiny amounts of specific substances in biological samples. It works based on competition between antigens for antibody binding sites.
Here's how the RIA procedure works:
- A known quantity of radioactively labeled antigen (called the tracer) is added to the sample.
- The unlabeled antigen naturally present in the sample competes with the tracer for binding sites on a limited amount of specific antibody.
- As the concentration of unlabeled antigen increases, less of the labeled tracer can bind to the antibody (it gets "crowded out").
- The amount of bound labeled antigen is measured using a gamma counter.
- A standard curve is generated using known antigen concentrations. By comparing the sample's measurement to this curve, you can determine the unknown concentration.
RIA can measure a wide range of substances:
- Hormones such as insulin, thyroid hormones, and steroid hormones
- Drugs and their metabolites
- Tumor markers like prostate-specific antigen (PSA) and alpha-fetoprotein (AFP)
- Infectious agents such as hepatitis B surface antigen
The key advantages of RIA are its high sensitivity (it can detect substances at very low concentrations) and high specificity (minimal cross-reactivity with other substances). It works with various biological fluids including blood, urine, and saliva.
While RIA remains an important technique, other methods like enzyme-linked immunosorbent assay (ELISA) and chemiluminescent immunoassay (CLIA) have become more common in clinical labs because they avoid the use of radioactive materials. RIA results can also be complemented by other diagnostic procedures such as biopsy for definitive diagnosis, or endoscopy for visual examination and sample collection.